118
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Racial and ethnic disparities in surgery for kidney cancer: a SEER analysis, 2007–2014

ORCID Icon, , &
Pages 1103-1114 | Received 11 Mar 2021, Accepted 04 May 2023, Published online: 10 May 2023

References

  • Altekruse, S. F., L. Dickie, X. C. Wu, M. C. Hsieh, M. Wu, R. Lee, and S. Delacroix Jr. 2014. “Clinical and Prognostic Factors for Renal Parenchymal, Pelvis, and Ureter Cancers in SEER Registries: Collaborative Stage Data Collection System, Version 2.” Cancer 120: 3826–3835. doi:10.1002/cncr.29051
  • American Cancer Society. 2017. “Active Surveillance for Kidney Cancer.” Accessed May 2, 2018. https://www.cancer.org/cancer/kidney-cancer/treating/active-surveillence.html.
  • American Cancer Society. 2018. “Key Statistics About Kidney Cancer.” Accessed April 4, 2018. https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html.
  • Batai, K., A. Harb-De la Rosa, A. Lwin, F. Chaus, F. C. Gachupin, E. Price, and B. R. Lee. 2019. “Racial and Ethnic Disparities in Renal Cell Carcinoma: An Analysis of Clinical Characteristics.” Clinical Genitourinary Cancer 17: e195–e202. doi:10.1016/j.clgc.2018.10.012
  • Camacho-Rivera, M., C. J. Gonzalez, J. A. Morency, K. D. Blake, and R. Calixte. 2020. “Heterogeneity in Trust of Cancer Information among Hispanic Adults in the United States: An Analysis of the Health Information National Trends Survey.” Cancer Epidemiology, Biomarkers & Prevention 29: 1348–1356. doi:10.1158/1055-9965.EPI-19-1375
  • Chow, W. H., B. Shuch, W. M. Linehan, and S. S. Devesa. 2013. “Racial Disparity in Renal Cell Carcinoma Patient Survival According to Demographic and Clinical Characteristics.” Cancer 119: 388–394. doi:10.1002/cncr.27690
  • Cykert, S., P. Dilworth-Anderson, M. H. Monroe, P. Walker, F. R. McGuire, G. Corbie-Smith, L. J. Edwards, and A. J. Bunton. 2010. “Factors Associated with Decisions to Undergo Surgery among Patients with Newly Diagnosed Early-Stage Lung Cancer.” JAMA 303 (23): 2368–2376. doi:10.1001/jama.2010.793
  • Esnaola, N. F., and M. E. Ford. 2012. “Racial Differences and Disparities in Cancer Care and Outcomes” Surgical Oncology Clinics of North America 21 (3): 417–437. doi:10.1016/j.soc.2012.03.012
  • Everett, M. R., W. May, C. T. Nowels, and D. S. Main. 2005. “Recruitment, Retention, and Training of African American and Latino Standardized Patients: A Collaborative Study.” JIAMSE 15 (2): 74–80.
  • Gachupin, F. C., B. R. Lee, J. Chipollini, K. R. Pulling, A. Cruz, A. C. Wong, C. I. Valencia, C. H. Hsu, and K. Batai. 2022. “Renal Cell Carcinoma Surgical Treatment Disparities in American Indian/Alaska Natives and Hispanic Americans in Arizona.” International Journal of Environmental Research and Public Health 19: 1185. doi:10.3390/ijerph19031185
  • Howard, J. M., K. Nandy, S. L. Woldu, and V. Margulis. 2021. “Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States.” JAMA Network Open 4: e2112813. doi:10.1001/jamanetworkopen.2021.12813
  • Javier-DesLoges, J., T. J. Nelson, J. D. Murphy, R. R. McKay, T. F. Stewart, A. K. Kader, I. Derweesh, M. E. Martinez, and B. S. Rose. 2022. “An Evaluation of Trends in the Representation of Patients by age, sex, and Diverse Race/Ethnic Groups in Bladder and Kidney Cancer Clinical Trials.” Urologic Oncology 40 (199): e15–199.e21. doi:10.1016/j.urolonc.2022.03.013
  • Karliner, L. S., E. S. Hwang, D. Nickleach, and C. P. Kaplan. 2011. “Language Barriers and Patient-Centered Breast Cancer Care.” Patient Education and Counseling 84: 223–228. doi:10.1016/j.pec.2010.07.009
  • Lathan, C. S., B. A. Neville, and C. C. Earle. 2006. “The Effect of Race on Invasive Staging and Surgery in Non-Small-Cell Lung Cancer.” Journal of Clinical Oncology 24 (3): 413–418. doi:10.1200/JCO.2005.02.1758
  • Natale-Pereira, A., K. R. Enard, L. Nevarez, and L. A. Jones. 2011. “The Role of Patient Navigators in Eliminating Health Disparities.” Cancer 117: 3541–3550. doi:10.1002/cncr.26264
  • National Cancer Institute. 2018a. “Cancer Stat Facts: Kidney and Renal Pelvis Cancer.” Accessed April 4, 2018. https://seer.cancer.gov/statfacts/html/kidrp.html.
  • National Cancer Institute. 2018b. “Renal Cell Cancer Treatment (PDQ®)–Health Professional Version.” Accessed April 4, 2018. https://www.cancer.gov/types/kidney/hp/kidney-treatment-pdq.
  • National Cancer Institute. 2018c. “Renal Cell Cancer Treatment (PDQ®)–Patient Version.” Accessed April 4, 2018. https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq.
  • National Cancer Institute Surveillance, Epidemiology, and End Results Program. “Overview of the SEER Program.” Accessed May 2, 2018. https://seer.cancer.gov/about/overview.html.
  • National Cancer Institute Surveillance, Epidemiology, and End Results Program. 2003. “SEER Site-Specific Surgery of Primary Site Codes.” Accessed July 16, 2018. https://seer.cancer.gov/archive/manuals/historic/AppendD.pdf.
  • Patel, S. H., S. Ebrahimi, D. W. Northfelt, T. E. Mathews, F. M. Omar, E. D. Martinez, T. A. DeWees, and J. M. Okamoto. 2020. “Understanding American Indian Perceptions Toward Radiation Therapy.” Cancer Control 27: 107327482094599. doi:10.1177/1073274820945991
  • Patel, H. D., M. Kates, P. M. Pierorazio, E. S. Hyams, M. A. Gorin, M. W. Ball, S. B. Bhayani, X. Hui, C. B. Thompson, and M. E. Allaf. 2014. “Survival After Diagnosis of Localized T1a Kidney Cancer: Current Population-Based Practice of Surgery and Nonsurgical Management.” Urology 83: 126–133. doi:10.1016/j.urology.2013.08.088
  • Siegel, R. L., K. D. Miller, N. S. Wagle, and A. Jemal. 2023. “Cancer Statistics, 2023.” CA: A Cancer Journal for Clinicians 73: 17–48. doi:10.3322/caac.21763
  • Street, R. L. Jr, K. J. O’Malley, L. A. Cooper, and P. Haidet. 2008. “Understanding Concordance in Patient-Physician Relationships: Personal and Ethnic Dimensions of Shared Identity.” Annals of Family Medicine 6: 198–205. doi:10.1370/afm.821
  • Suarez-Sarmiento, A., X. Yao, J. N. Hofmann, J. S. Syed, W. K. Zhao, M. P. Purdue, W. H. Chow, D. Corley, and B. Shuch. 2017. “Ethnic Disparities in Renal Cell Carcinoma: An Analysis of Hispanic Patients in a Single-Payer Healthcare System.” International Journal of Urology 24: 765–770. doi:10.1111/iju.13424
  • Volpe, A., and M. A. S. Jewett. 2005. “The Natural History of Small Renal Masses.” Nature Clinical Practice Urology 2: 384–390. doi:10.1038/ncpuro0254
  • Wang, J., F. W. Wang, and A. Kessinger. 2011. “The Natural History and Outcomes of the Patients with Carcinosarcoma Involving Kidney and Renal Pelvis.” Advances in Urology 2011: 1–5. doi:10.1155/2011/693964
  • Zini, L., U. Capitanio, P. Perrotte, C. Jeldres, S. F. Shariat, P. Arjane, H. Widmer, F. Montorsi, J. J. Patard, and P. I. Karakiewicz. 2009. “Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus no Surgery in Patients with Metastatic Renal Cell Carcinoma.” Urology 73: 342–346. doi:10.1016/j.urology.2008.09.022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.